Greenlanders Protest New US Consulate as Trumps Greenland Ambitions Spark Tensions Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project AntiBeta ETFs A Potential Shield as Growth Stocks Face Headwinds Amazon Expands AI Shopping Technology to Retail Partners Signs Kate Spade as First Customer Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Berkshire Hathaway Revamps Portfolio New Stakes in Delta Air Lines Alphabet Increase Burlington Stores BURL Q1 2026 Earnings EPS Beats Estimates Amid Modest Sales Performance Diageo DEO Q1 2026 Earnings EPS Misses Estimates Amid Volume Pressures Stock Edges Higher HPK Q1 2026 Earnings Significant Earnings Miss as EPS Falls to 102 APWC Q3 1997 Earnings EPS Misses Estimates Amid Cost Pressures Tuya Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Unchanged RXO Q1 2026 Earnings EPS Slightly Beats Estimates Amid Challenging Freight Market Critical Metals Corp Faces Resistance Near 12 as Shares Edge Lower but Support Holds at 11 Select Medical Holdings SEM Holds Steady at 1652 Amid Narrow Trading Range FG Merger II Corp Rights FGMCR Holds Near Key Support After Marginal Decline PIMCO Access Income Fund PAXS Holds Steady as Market Awaits Direction Alerus Financial ALRS Edges Higher as Stock Nears Resistance at 3034 Lessons from Ebola Outbreak Speed Funding and Compassion May Guide Future Pandemic Preparedness Deckers Outdoor DECK Q1 2026 Earnings EPS Surges Past Estimates Stock Climbs on Strong Start Senti Biosciences Edges Higher Near Key Resistance Level Centurion Acquisition Corp Warrant ALFUW Holds Steady at 014 Amidst RangeBound Trading Rezolute Inc RZLT Pushes Higher on Modest Volume as Traders Eye Biotech Catalysts Sentage Holdings Inc SNTG Edges Higher Amid Consolidation Near Key Resistance Invest Green Acquisition Corporation IGAC Holds Steady at 998 Amid Neutral Trading Adeia Inc ADEA Edges Higher Analyzing the Latest Price Move and Key Levels TTEC Holdings Inc Modestly Rises as Stock Tests Key Resistance Prelude Therapeutics PRLD Extends Gains Support Holds Resistance in Focus